Emerald Advisers’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
Emerald Advisers's BLUE Position: Q4 2020 in Review
Emerald Advisers sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 4 shares — an estimated $3K sold.
Emerald Advisers first reported a position in BLUE in Q3 2014 and held it in 18 quarters. The position peaked at $25.3M in Q3 2016. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.
- Emerald Advisers reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
- Emerald Advisers sold 4 bluebird bio shares in Q4 2020, an estimated $3K.
- Emerald Advisers first reported a position in bluebird bio in Q3 2014 and held it in 18 quarters.
- Emerald Advisers's bluebird bio position peaked at $25.3M in Q3 2016.
- 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.
Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.